India Still Viable for Drug Innovation, Hisey Says

April 1 (Bloomberg) -- Terry Hisey, vice chairman and U.S. life sciences leader at Deloitte LLP, talks about a ruling by India's Supreme Court denying Novartis AG's request for patent protection for its Gleevec cancer treatment. He speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Does Apple TV Need a Revamp?
07:16 - Homebrew VC Partner Hunter Walk, Technalysis Founder Bob O’Donnell and IDC Chief Research Officer Crawford Del Prete discuss Apple to unveil a new TV box this fall and the future of Apple’s streaming service. They speak with Bloomberg’s Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Why Would Microsoft Invest in Uber?
  • Why U.S. Wage Growth Has Screeched to a Halt
  • The China Slowdown Felt Around the World